Search Count: 16
 |
Structure Of Cc Chemokine Receptor 2 With Orthosteric And Allosteric Antagonists
Organism: Homo sapiens, Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2016-12-14 Classification: SIGNALING PROTEIN Ligands: 73R, VT5, SO4, OLC, ZN |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40W |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Y, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40X, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Z, GOL |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
 |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2QA |
 |
Correlation Between Chemotype-Dependent Binding Conformations Of Hsp90 Alpha/Beta And Isoform Selectivity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2014-01-22 Classification: CHAPERONE Ligands: 2LC |
 |
Correlation Between Chemotype-Dependent Binding Conformations Of Hsp90 Alpha/Beta And Isoform Selectivity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-01-15 Classification: CHAPERONE Ligands: E0G, GOL |
 |
Correlation Between Chemotype-Dependent Binding Conformations Of Hsp90 Alpha/Beta And Isoform Selectivity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2014-01-15 Classification: CHAPERONE Ligands: 2LC |
 |
Crystal Structure Of Staphylococcus Aureus Gyrase B Co-Complexed With 4-Methyl-5-[3-(Methylsulfanyl)-1H-Pyrazol-5-Yl]-2-Thiophen-2-Yl-1,3-Thiazole Inhibitor
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2010-02-09 Classification: Isomerase/Isomerase inhibitor Ligands: B48 |
 |
Staphylococcus Aureus Gyrase B Co-Complex With Methyl ({5-[4-(4-Hydroxypiperidin-1-Yl)-2-Phenyl-1,3-Thiazol-5-Yl]-1H-Pyrazol-3-Yl}Methyl)Carbamate Inhibitor
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2010-02-09 Classification: Isomerase/Isomerase inhibitor Ligands: B47 |
 |
Crystal Structure Of E. Coli Gyrase B Co-Complexed With Prop-2-Yn-1-Yl {[5-(4-Piperidin-1-Yl-2-Pyridin-3-Yl-1,3-Thiazol-5-Yl)-1H-Pyrazol-3-Yl]Methyl}Carbamate Inhibitor
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2010-02-09 Classification: Isomerase/Isomerase inhibitor Ligands: B46 |